Yoowannakul Suree, Harris Lauren S, Davenport Andrew
UCL Center for Nephrology, Royal Free Hospital, University College London, London, UK.
Ther Apher Dial. 2018 Apr;22(2):171-177. doi: 10.1111/1744-9987.12647. Epub 2018 Jan 4.
Peritoneal protein clearance (PPCl) depends upon vascular supply and size selective permeability. Some previous reports suggested PPCl can distinguish fast peritoneal membrane transport due to local or systemic inflammation. However, as studies have been discordant, we wished to determine factors associated with an increased PPCl. Consecutive patients starting peritoneal dialysis (PD) who were peritonitis-free were studied. Data included a baseline peritoneal equilibration test (PET), measurement of dialysis adequacy, 24-h dialysate PPCl and body composition measured by multifrequency bioimpedance. 411 patients, mean age 57.2 ± 16.6 years, 60.8% male, 39.4% diabetic, 20.2% treated by continuous ambulatory peritoneal dialysis (CAPD) were studied. Mean PET 4-h Dialysate/Serum creatinine was 0.73 ± 0.13, with daily peritoneal protein loss 4.6 (3.3-6.4) g, and median PPCl 69.6 (49.1-99.6) mL/day. On multivariate analysis, PPCl was most strongly associated with CAPD (β 0.25, P < 0.001), extracellular water (ECW)/total body water (TBW) ratio (β 0.21, P < 0.001), skeletal muscle mass index (β 0.21, P < 0.001), log N-terminal brain natriuretic peptide (NT-proBNP) (β 0.17, P = 0.001), faster PET transport (β 0.15, P = 0.005), and normalized nitrogen appearance rate (β 0.13, P = 0.008). In addition to the longer dwell times of CAPD, greater peritoneal creatinine clearance and faster PET transporter status, we observed an association between increased PPCl and ECW expansion, increased NT-proBNP, estimated dietary protein intake and muscle mass, suggesting a link to sodium intake and sodium balance, increasing both ECW and conduit artery hydrostatic pressure resulting in greater vascular protein permeability. This latter association may explain reports linking PPCl to patient mortality.
腹膜蛋白清除率(PPCl)取决于血管供应和大小选择性通透性。先前的一些报告表明,PPCl可区分因局部或全身炎症导致的快速腹膜转运。然而,由于研究结果不一致,我们希望确定与PPCl增加相关的因素。对开始进行腹膜透析(PD)且无腹膜炎的连续患者进行了研究。数据包括基线腹膜平衡试验(PET)、透析充分性测量、24小时透析液PPCl以及通过多频生物阻抗测量的身体成分。共研究了411例患者,平均年龄57.2±16.6岁,男性占60.8%,糖尿病患者占39.4%,20.2%接受持续性非卧床腹膜透析(CAPD)治疗。PET 4小时透析液/血清肌酐的平均值为0.73±0.13,每日腹膜蛋白丢失为4.6(3.3 - 6.4)g,PPCl中位数为69.6(49.1 - 99.6)mL/天。多变量分析显示,PPCl与CAPD(β 0.25,P < 0.001)、细胞外液(ECW)/总体液(TBW)比值(β 小 0.21,P < 0.001)、骨骼肌质量指数(β 0.21,P < 0.001)、对数N末端脑钠肽(NT - proBNP)(β 0.17,P = 0.001)、更快的PET转运(β 0.15,P = 0.005)以及标准化氮出现率(β 0.13,P = 0.008)最为密切相关。除了CAPD的驻留时间更长、腹膜肌酐清除率更高以及PET转运状态更快外,我们还观察到PPCl增加与ECW扩张、NT - proBNP升高、估计的饮食蛋白摄入量和肌肉质量之间存在关联,这表明与钠摄入和钠平衡有关,增加了ECW和导管动脉静水压,导致血管蛋白通透性更高。后一种关联可能解释了将PPCl与患者死亡率相关联的报告。